Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

ClinicalTrials.gov ID: NCT00216086

Public ClinicalTrials.gov record NCT00216086. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Preoperative Capecitabine Plus Irinotecan Followed by Combined Modality Capecitabine and Radiation for Locally Advanced Rectal Cancer: Hoosier Oncology Group GI03-53

Study identification

NCT ID
NCT00216086
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gabi Chiorean, MD
Other
Enrollment
22 participants

Conditions and interventions

Conditions

Interventions

  • Capecitabine Drug
  • Irinotecan Drug
  • EUS Procedure
  • Neoadjuvant Chemotherapy Drug
  • Preoperative Radiation Procedure
  • Surgery Procedure
  • Adjuvant Chemotherapy Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2005
Primary completion
Apr 30, 2008
Completion
Apr 30, 2008
Last update posted
Jun 5, 2016

2005 – 2008

United States locations

U.S. sites
9
U.S. states
1
U.S. cities
8
Facility City State ZIP Site status
Elkhart Clinic Elkhart Indiana 46515
Fort Wayne Oncology & Hematology, Inc Fort Wayne Indiana 46815
Center for Cancer Care at Goshen Health System Goshen Indiana 46527
Indiana University Cancer Center Indianapolis Indiana 46202
Quality Cancer Center (MCGOP) Indianapolis Indiana 46202
Medical Consultants, P.C. Muncie Indiana 47303
Center for Cancer Care, Inc., P.C. New Albany Indiana 47150
Northern Indiana Cancer Research Consortium South Bend Indiana 46601
AP&S Clinic Terre Haute Indiana 47804

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00216086, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2016 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00216086 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →